HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Establishing consensus criteria for the diagnosis of diabetes in pregnancy following the HAPO study.

Abstract
The current diagnostic criteria for gestational diabetes mellitus are controversial because they lack correlation to maternal and perinatal outcome. The results of the hyperglycemia and adverse pregnancy outcome (HAPO) study demonstrate a linear association between increasing levels of fasting, 1- and 2-h plasma glucose post a 75 g oral glucose tolerance test to several significant outcome endpoints, such as birth weight above the 90th percentile, cord blood serum C-peptide level above the 90th percentile, primary cesarean delivery, clinical neonatal hypoglycemia, premature delivery, shoulder dystocia or birth injury, intensive neonatal care admission, hyperbilirubinemia, and preeclampsia. A consensus report by the IADPSG, based on a vigorous assessment of the HAPO results and other studies, recommended an endorsement of risk-based, internationally accepted criteria for the diagnosis and classification of diabetes in pregnancy. This review follows the steps from defining the problem to the endpoint of achieving a worldwide policy change.
AuthorsEran Hadar, Moshe Hod
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 1205 Pg. 88-93 (Sep 2010) ISSN: 1749-6632 [Electronic] United States
PMID20840258 (Publication Type: Evaluation Study, Journal Article, Review)
Copyright© 2010 New York Academy of Sciences.
Chemical References
  • Blood Glucose
Topics
  • Blood Glucose (analysis)
  • Consensus
  • Diabetes, Gestational (blood, diagnosis)
  • Female
  • Glucose Tolerance Test
  • Humans
  • Hyperglycemia (blood, complications, diagnosis)
  • Pregnancy
  • Pregnancy Complications (blood, diagnosis)
  • Pregnancy Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: